Epigenomics AG (EPGNF)
USD 0.79
(0.0%)
USD 0.79
(0.0%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | -5.23 EUR | 64.61% |
| 2022 | -14.78 EUR | -241.34% |
| 2021 | -4.33 EUR | 89.08% |
| 2020 | -39.67 EUR | 44.63% |
| 2019 | -71.65 EUR | -386.09% |
| 2018 | -14.74 EUR | -17.08% |
| 2017 | -12.59 EUR | 19.76% |
| 2016 | -15.69 EUR | -4.88% |
| 2015 | -14.96 EUR | 19.18% |
| 2014 | -18.51 EUR | -4.69% |
| 2013 | -17.68 EUR | 55.02% |
| 2012 | -39.31 EUR | 14.65% |
| 2011 | -46.06 EUR | -24.42% |
| 2010 | -37.02 EUR | -305.03% |
| 2009 | -9.14 EUR | 25.69% |
| 2008 | -12.30 EUR | 36.14% |
| 2007 | -19.26 EUR | 18.87% |
| 2006 | -23.74 EUR | -268.61% |
| 2005 | 14.08 EUR | -32.5% |
| 2004 | 20.86 EUR | 1.26% |
| 2003 | 20.60 EUR | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 FY | - EUR | 64.61% |
| 2023 Q4 | 2.20 EUR | 0.0% |
| 2023 Q2 | -3.09 EUR | 52.82% |
| 2023 Q1 | -6.55 EUR | 17.61% |
| 2023 Q3 | 2.20 EUR | 171.2% |
| 2022 Q3 | -0.38 EUR | -18.75% |
| 2022 Q1 | -0.67 EUR | 70.09% |
| 2022 Q4 | -7.95 EUR | -1992.11% |
| 2022 FY | - EUR | -241.34% |
| 2022 Q2 | -0.32 EUR | 52.24% |
| 2021 Q3 | 0.92 EUR | 210.84% |
| 2021 Q4 | -2.24 EUR | -343.48% |
| 2021 FY | - EUR | 89.08% |
| 2021 Q1 | -0.82 EUR | 90.44% |
| 2021 Q2 | -0.83 EUR | -1.22% |
| 2020 FY | - EUR | 44.63% |
| 2020 Q3 | -1.87 EUR | 16.89% |
| 2020 Q1 | -2.15 EUR | 92.14% |
| 2020 Q2 | -2.25 EUR | -4.65% |
| 2020 Q4 | -8.58 EUR | -358.82% |
| 2019 FY | - EUR | -386.09% |
| 2019 Q1 | -2.18 EUR | 87.56% |
| 2019 Q2 | -3.73 EUR | -71.1% |
| 2019 Q3 | -2.26 EUR | 39.41% |
| 2019 Q4 | -27.34 EUR | -1109.73% |
| 2018 Q3 | -3.78 EUR | -16.31% |
| 2018 FY | - EUR | -17.08% |
| 2018 Q1 | -4.10 EUR | 76.53% |
| 2018 Q2 | -3.25 EUR | 20.73% |
| 2018 Q4 | -17.52 EUR | -363.49% |
| 2017 FY | - EUR | 19.76% |
| 2017 Q1 | -2.85 EUR | 67.8% |
| 2017 Q3 | -1.40 EUR | 72.76% |
| 2017 Q2 | -5.14 EUR | -80.35% |
| 2017 Q4 | -17.47 EUR | -1147.86% |
| 2016 Q2 | -4.68 EUR | 28.98% |
| 2016 FY | - EUR | -4.88% |
| 2016 Q4 | -8.85 EUR | -173.15% |
| 2016 Q3 | -3.24 EUR | 30.77% |
| 2016 Q1 | -6.59 EUR | 21.73% |
| 2015 Q3 | -3.86 EUR | 6.54% |
| 2015 Q4 | -8.42 EUR | -118.13% |
| 2015 Q2 | -4.13 EUR | 28.42% |
| 2015 Q1 | -5.77 EUR | 82.58% |
| 2015 FY | - EUR | 19.18% |
| 2014 Q1 | -4.80 EUR | 82.43% |
| 2014 FY | - EUR | -4.69% |
| 2014 Q4 | -33.13 EUR | -753.87% |
| 2014 Q3 | -3.88 EUR | -1.04% |
| 2014 Q2 | -3.84 EUR | 20.0% |
| 2013 Q2 | -3.89 EUR | 12.98% |
| 2013 Q3 | -4.45 EUR | -14.4% |
| 2013 Q4 | -27.32 EUR | -513.93% |
| 2013 FY | - EUR | 55.02% |
| 2013 Q1 | -4.47 EUR | 0.0% |
| 2012 Q2 | -10.01 EUR | -32.93% |
| 2012 FY | - EUR | 14.65% |
| 2012 Q1 | -7.53 EUR | 0.0% |
| 2012 Q3 | -11.90 EUR | -18.88% |
| 2012 Q4 | - EUR | 100.0% |
| 2011 FY | - EUR | -24.42% |
| 2011 Q1 | -8.55 EUR | 0.0% |
| 2011 Q2 | -8.90 EUR | -4.09% |
| 2011 Q3 | -14.24 EUR | -60.0% |
| 2011 Q4 | - EUR | 100.0% |
| 2010 Q1 | -2.30 EUR | 0.0% |
| 2010 Q4 | - EUR | 100.0% |
| 2010 Q3 | -8.79 EUR | -432.73% |
| 2010 Q2 | -1.65 EUR | 28.26% |
| 2010 FY | - EUR | -305.03% |
| 2009 Q3 | -2.00 EUR | 5.66% |
| 2009 FY | - EUR | 25.69% |
| 2009 Q1 | -2.21 EUR | 0.0% |
| 2009 Q2 | -2.12 EUR | 4.07% |
| 2009 Q4 | - EUR | 100.0% |
| 2008 FY | - EUR | 36.14% |
| 2007 FY | - EUR | 18.87% |
| 2006 FY | - EUR | -268.61% |
| 2005 FY | - EUR | -32.5% |
| 2004 FY | - EUR | 1.26% |
| 2003 FY | - EUR | 0.0% |